Synthesis and antimalarial evaluation of new N1-(7-chloro-4-quinolyl)-1,4-bis(3-aminopropyl)piperazine derivatives. 2005

Adina Ryckebusch, and Marie-Ange Debreu-Fontaine, and Elisabeth Mouray, and Philippe Grellier, and Christian Sergheraert, and Patricia Melnyk
Institut de Biologie et Institut Pasteur de Lille-UMR CNRS 8525-Université de Lille II 1 rue du Professeur Calmette, B.P. 447, 59021 Lille, France.

Synthesis and evaluation of the activity of new N(1)-(7-chloro-4-quinolyl)-1,4-bis(3-aminopropyl)piperazine derivatives against a chloroquine-resistant strain of Plasmodium falciparum are described. Selectivity indices were improved for two compounds versus the lead 1, the bis-cyclopropylmethyl derivative, thus increasing the therapeutic interest of our family. As our previous studies conducted on the mode of action of our compounds made us hypothesize the existence of original mechanisms and/or original targets, terminal amino derivatives can be considered as promising tools further mechanistical studies, as probes for affinity chromatography.

UI MeSH Term Description Entries
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D010963 Plasmodium falciparum A species of protozoa that is the causal agent of falciparum malaria (MALARIA, FALCIPARUM). It is most prevalent in the tropics and subtropics. Plasmodium falciparums,falciparums, Plasmodium
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002738 Chloroquine The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses. Aralen,Arechine,Arequin,Chingamin,Chlorochin,Chloroquine Sulfate,Chloroquine Sulphate,Khingamin,Nivaquine,Sulfate, Chloroquine,Sulphate, Chloroquine
D002846 Chromatography, Affinity A chromatographic technique that utilizes the ability of biological molecules, often ANTIBODIES, to bind to certain ligands specifically and reversibly. It is used in protein biochemistry. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Chromatography, Bioaffinity,Immunochromatography,Affinity Chromatography,Bioaffinity Chromatography
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000962 Antimalarials Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) Anti-Malarial,Antimalarial,Antimalarial Agent,Antimalarial Drug,Anti-Malarials,Antimalarial Agents,Antimalarial Drugs,Agent, Antimalarial,Agents, Antimalarial,Anti Malarial,Anti Malarials,Drug, Antimalarial,Drugs, Antimalarial
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D020128 Inhibitory Concentration 50 The concentration of a compound needed to reduce population growth of organisms, including eukaryotic cells, by 50% in vitro. Though often expressed to denote in vitro antibacterial activity, it is also used as a benchmark for cytotoxicity to eukaryotic cells in culture. IC50,Concentration 50, Inhibitory

Related Publications

Adina Ryckebusch, and Marie-Ange Debreu-Fontaine, and Elisabeth Mouray, and Philippe Grellier, and Christian Sergheraert, and Patricia Melnyk
February 2009, Journal of enzyme inhibition and medicinal chemistry,
Adina Ryckebusch, and Marie-Ange Debreu-Fontaine, and Elisabeth Mouray, and Philippe Grellier, and Christian Sergheraert, and Patricia Melnyk
March 1970, The Journal of pharmacology and experimental therapeutics,
Adina Ryckebusch, and Marie-Ange Debreu-Fontaine, and Elisabeth Mouray, and Philippe Grellier, and Christian Sergheraert, and Patricia Melnyk
September 1969, Toxicology and applied pharmacology,
Adina Ryckebusch, and Marie-Ange Debreu-Fontaine, and Elisabeth Mouray, and Philippe Grellier, and Christian Sergheraert, and Patricia Melnyk
July 2010, Bioorganic & medicinal chemistry,
Adina Ryckebusch, and Marie-Ange Debreu-Fontaine, and Elisabeth Mouray, and Philippe Grellier, and Christian Sergheraert, and Patricia Melnyk
May 1981, Bollettino chimico farmaceutico,
Adina Ryckebusch, and Marie-Ange Debreu-Fontaine, and Elisabeth Mouray, and Philippe Grellier, and Christian Sergheraert, and Patricia Melnyk
March 2001, Yao xue xue bao = Acta pharmaceutica Sinica,
Adina Ryckebusch, and Marie-Ange Debreu-Fontaine, and Elisabeth Mouray, and Philippe Grellier, and Christian Sergheraert, and Patricia Melnyk
December 2017, Journal of enzyme inhibition and medicinal chemistry,
Adina Ryckebusch, and Marie-Ange Debreu-Fontaine, and Elisabeth Mouray, and Philippe Grellier, and Christian Sergheraert, and Patricia Melnyk
November 2011, Medicinal chemistry (Shariqah (United Arab Emirates)),
Adina Ryckebusch, and Marie-Ange Debreu-Fontaine, and Elisabeth Mouray, and Philippe Grellier, and Christian Sergheraert, and Patricia Melnyk
January 2000, Bioorganic & medicinal chemistry,
Adina Ryckebusch, and Marie-Ange Debreu-Fontaine, and Elisabeth Mouray, and Philippe Grellier, and Christian Sergheraert, and Patricia Melnyk
January 2012, Bioinorganic chemistry and applications,
Copied contents to your clipboard!